Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of NovoCure Ltd (NASDAQ: NVCR) was $15.53 for the day, down -0.13% from the previous closing price of $15.55. In other words, the price has decreased by -$0.13 from its previous closing price. On the day, 0.9 million shares were traded. NVCR stock price reached its highest trading level at $16.245 during the session, while it also had its lowest trading level at $15.31.
Ratios:
Our analysis of NVCR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.99 and its Current Ratio is at 6.26. In the meantime, Its Debt-to-Equity ratio is 1.66 whereas as Long-Term Debt/Eq ratio is at 1.66.
On August 28, 2023, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $85 to $25.
Piper Sandler Upgraded its Neutral to Overweight on August 08, 2023, while the target price for the stock was maintained at $45.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’24 when GROENHUYSEN WILHELMUS CM sold 1,217 shares for $16.01 per share. The transaction valued at 19,484 led to the insider holds 251,235 shares of the business.
Leonard Frank X sold 840 shares of NVCR for $13,448 on Mar 04 ’24. The EVP, Pres., Novocure Oncology now owns 160,098 shares after completing the transaction at $16.01 per share. On Mar 01 ’24, another insider, GROENHUYSEN WILHELMUS CM, who serves as the Chief Operating Officer of the company, sold 2,107 shares for $16.03 each. As a result, the insider received 33,769 and left with 252,452 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVCR now has a Market Capitalization of 1671198848 and an Enterprise Value of 1396313088. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.18 while its Price-to-Book (P/B) ratio in mrq is 4.65. Its current Enterprise Value per Revenue stands at 2.656 whereas that against EBITDA is -7.138.
Stock Price History:
Over the past 52 weeks, NVCR has reached a high of $83.60, while it has fallen to a 52-week low of $10.87. The 50-Day Moving Average of the stock is 9.39%, while the 200-Day Moving Average is calculated to be -8.08%.
Shares Statistics:
NVCR traded an average of 1.30M shares per day over the past three months and 1152130 shares per day over the past ten days. A total of 107.08M shares are outstanding, with a floating share count of 96.75M. Insiders hold about 10.09% of the company’s shares, while institutions hold 81.14% stake in the company. Shares short for NVCR as of 1713139200 were 6035477 with a Short Ratio of 4.64, compared to 1710460800 on 5541325. Therefore, it implies a Short% of Shares Outstanding of 6035477 and a Short% of Float of 6.710000000000001.
